Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 15;523(1):15-32.
doi: 10.1016/j.ijpharm.2017.03.019. Epub 2017 Mar 19.

Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges

Ghareb M Soliman  1
Affiliations
Review

Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges

Ghareb M Soliman. Int J Pharm. .

Abstract

Invasive fungal infections are becoming a major health concern in several groups of patients leading to severe morbidity and mortality. Moreover, cutaneous fungal infections are a major cause of visits to outpatient dermatology clinics. Despite the availability of several effective agents in the antifungal drug arena, their therapeutic outcome is less than optimal due to limitations related to drug physicochemical properties and toxicity. For instance, poor aqueous solubility limits the formulation options and efficacy of several azole antifungal drugs while toxicity limits the benefits of many other drugs. Nanoparticles hold great promise to overcome these limitations due to their ability to enhance drug aqueous solubility, bioavailability and antifungal efficacy. Further, drug incorporation into nanoparticles could greatly reduce its toxicity. Despite these interesting nanoparticle features, there are only few marketed nanoparticle-based antifungal drug formulations. This review sheds light on different classes of nanoparticles used in antifungal drug delivery, such as lipid-based vesicles, polymeric micelles, solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions and dendrimers with emphasis on their advantages and limitations. Translation of these nanoformulations from the lab to the clinic could be facilitated by focusing the research on overcoming problems related to nanoparticle stability, drug loading and high cost of production and standardization.

Keywords: Amphotericin B; Amphotericin B (PubChem CID: 5280965); Antifungal drugs; Clotrimazole (PubChem CID: 2812); Dendrimers; Fluconazole (PubChem CID: 3365); Fungal infections; Griseofulvin (PubChem CID: 441140); Itraconazole (PubChem CID: 55283); Ketoconazole (PubChem CID: 456201); Liposomes; Micelles; Miconazole (PubChem CID: 4189); Nanoemulsions; Nanoparticles; Nystatin (PubChem CID: 6433272).

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Substances

LinkOut - more resources

  NODES
admin 2
Note 1
twitter 2